Lutetium-177 vipivotide tetraxetan for treating PSMA-positive hormone-relapsed metastatic prostate cancer after an anti-androgen but not a taxane (terminated evaluation)
Technology appraisal
Reference number: TA1179
Published:
Tools and resources
Tools and resources to help you put the guidance into practice.